Stereotaxis Completes Robocath Acquisition, Issues 1.47 Million Shares and Warrants
Stereotaxis completed its acquisition of 100% of Robocath, a French surgical robotics company, on July 7, 2026, for approximately $20 million in cash and common stock. The filing says the company issued 1,469,485 common shares, pre-funded warrants for 4,575,143 shares, and 225,000 shares to Robocath's financial advisor, with up to $25.0 million more in possible earnout consideration.
Key points
- Acquisition closed July 7, 2026; total consideration approximately $20 million in cash and common stock
- Issued 1,469,485 common shares and pre-funded warrants to buy 4,575,143 shares, exercisable until July 7, 2031
- Issued 225,000 shares to Robocath's financial advisor as partial success fee payment
- Earnout could add up to $25.0 million in shares or warrants, subject to targets, market value and adjustments
The filing
Written by AI on Nov 9, 2026, 8:36 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on July 09, 2026.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.